ANDA 63100, held by Teva Pharms USA. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 63100 (Tobramycin Sulfate), held by Teva Pharms USA, was first approved by FDA on Jan 30, 1992, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 30, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin SulfateEQ 40MG BASE/ML · injectable;injection | Tobramycin Sulfate | Discontinued |
| Feb 10, 2023 | Supplement 25Labeling · Standard review | Approved | None posted |
| Jan 18, 2023 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jan 18, 2023 | Supplement 22Labeling · Standard review | Approved | None posted |
| Jan 11, 2023 | Supplement 19Labeling · Standard review | Approved | None posted |
| Dec 9, 2010 | Supplement 9Labeling | Approved | None posted |
| Aug 9, 2000 | Supplement 7Labeling | Approved | None posted |
| Jul 13, 1999 | Supplement 6Labeling | Approved | None posted |
| Jun 2, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Apr 4, 1994 | Supplement 3Manufacturing | Approved | None posted |
| Dec 16, 1993 | Supplement 4Labeling | Approved | None posted |
| Mar 10, 1993 | Supplement 1Manufacturing | Approved | None posted |
| Mar 2, 1993 | Supplement 2Labeling | Approved | None posted |
| Jan 30, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters